It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ESAIY’s FA Score shows that 2 FA rating(s) are green whileOPTHF’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ESAIY’s TA Score shows that 4 TA indicator(s) are bullish while OPTHF’s TA Score has 3 bullish TA indicator(s).
ESAIY (@Pharmaceuticals: Other) experienced а -2.57% price change this week, while OPTHF (@Pharmaceuticals: Other) price change was -8.48% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.61%. For the same industry, the average monthly price growth was +1.68%, and the average quarterly price growth was -9.09%.
ESAIY is expected to report earnings on May 10, 2023.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
ESAIY | OPTHF | ESAIY / OPTHF | |
Capitalization | 18.3B | 12.5M | 146,400% |
EBITDA | 87.3B | -4.33M | -2,017,282% |
Gain YTD | -42.713 | -19.035 | 224% |
P/E Ratio | 46.08 | N/A | - |
Revenue | 744B | 190K | 391,578,947% |
Total Cash | 268B | 1.83M | 14,660,832% |
Total Debt | 126B | 86.5K | 145,664,740% |
ESAIY | OPTHF | |
---|---|---|
RSI ODDS (%) | 2 days ago64% | N/A |
Stochastic ODDS (%) | 2 days ago63% | 2 days ago90% |
Momentum ODDS (%) | 2 days ago77% | 2 days ago90% |
MACD ODDS (%) | 2 days ago82% | 2 days ago90% |
TrendWeek ODDS (%) | 2 days ago80% | 2 days ago90% |
TrendMonth ODDS (%) | 2 days ago80% | 2 days ago90% |
Advances ODDS (%) | 24 days ago60% | 9 days ago89% |
Declines ODDS (%) | 3 days ago70% | 2 days ago90% |
BollingerBands ODDS (%) | 2 days ago63% | 3 days ago90% |
Aroon ODDS (%) | 2 days ago77% | 2 days ago90% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WAESX | 17.24 | 0.11 | +0.64% |
Wasatch Emerging Markets Select Investor | |||
GMPPX | 38.23 | N/A | N/A |
Goldman Sachs Mid Cap Value P | |||
SMNIX | 28.19 | N/A | N/A |
Steward Equity Market Neutral I | |||
JWWFX | 113.95 | -0.82 | -0.71% |
Janus Henderson Global Research I | |||
RICEX | 59.11 | -4.91 | -7.67% |
American Funds Invmt Co of Amer R4 |
A.I.dvisor indicates that over the last year, ESAIY has been loosely correlated with SGIOY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ESAIY jumps, then SGIOY could also see price increases.
Ticker / NAME | Correlation To ESAIY | 1D Price Change % | ||
---|---|---|---|---|
ESAIY | 100% | +0.50% | ||
SGIOY - ESAIY | 37% Loosely correlated | -0.43% | ||
TAK - ESAIY | 36% Loosely correlated | +0.60% | ||
ESALF - ESAIY | 26% Poorly correlated | N/A | ||
OPTHF - ESAIY | 21% Poorly correlated | -1.95% | ||
BNXTF - ESAIY | 11% Poorly correlated | +2.90% | ||
More |